Trendingnow
Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026


By Sasha RogelbergAugust 28, 2026

By Kaitlyn Huamani and The Associated PressAugust 28, 2026

By Kamal AhmedAugust 27, 2026

By Catherina GioinoAugust 28, 2026
Latest stories from Fortune
More TechPage 53 of 100

By Emma BurleighMay 26, 2026

By Gerald Imray and The Associated PressMay 26, 2026

By Jocelyn Gecker and The Associated PressMay 26, 2026

By Preston ForeMay 26, 2026

By Aslesha MehtaMay 26, 2026

By Jeremy KahnMay 26, 2026

By Eric RiesMay 26, 2026

By Kristin StollerMay 26, 2026

By Nick LichtenbergMay 26, 2026

By Patrick Chun and Matt HigginsMay 26, 2026

By Lily Mae LazarusMay 26, 2026

By Nick LichtenbergMay 26, 2026

By Orianna Rosa RoyleMay 26, 2026

By Nicole Winfield, Kaitlyn Huamani, Paolo Santalucia and The Associated PressMay 25, 2026

By The Associated PressMay 25, 2026

By Oana Godeanu-Kenworthy and The ConversationMay 25, 2026

By Eva RoytburgMay 25, 2026

By Nick LichtenbergMay 25, 2026

By Emma BurleighMay 25, 2026

By Marco Quiroz-GutierrezMay 24, 2026

By Sasha RogelbergMay 24, 2026

By Nick LichtenbergMay 24, 2026

By Lydia BelangerMay 24, 2026

By Sydney LakeMay 24, 2026

By David S. BennahumMay 24, 2026

By Tristan BoveMay 24, 2026
Most Popular






















